BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26070970)

  • 1. Hippocampal glutamatergic/NMDA receptor functioning in bipolar disorder: A study combining mismatch negativity and proton magnetic resonance spectroscopy.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    Psychiatry Res; 2015 Aug; 233(2):88-94. PubMed ID: 26070970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the role of glutathione in mismatch negativity: An insight into NMDA receptor disturbances in bipolar disorder.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    Clin Neurophysiol; 2015 Jun; 126(6):1178-1184. PubMed ID: 25454340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the glutamatergic processes underlying mismatch negativity deficits in early stage bipolar disorder and schizophrenia: A combined
    Kaur M; Chitty KM; Lagopoulos J; Hickie IB; Duffy SL; Hermens DF
    J Psychiatr Res; 2019 Jun; 113():83-89. PubMed ID: 30921632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study.
    Chitty KM; Lagopoulos J; Kaur M; Hickie IB; Hermens DF
    Int J Neuropsychopharmacol; 2015 Jan; 18(6):. PubMed ID: 25603860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder.
    Chitty KM; Lagopoulos J; Lee RS; Hickie IB; Hermens DF
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1348-63. PubMed ID: 23968965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risky alcohol use predicts temporal mismatch negativity impairments in young people with bipolar disorder.
    Chitty KM; Kaur M; Lagopoulos J; Hickie IB; Hermens DF
    Biol Psychol; 2014 May; 99():60-8. PubMed ID: 24594113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.
    Rowland LM; Summerfelt A; Wijtenburg SA; Du X; Chiappelli JJ; Krishna N; West J; Muellerklein F; Kochunov P; Hong LE
    JAMA Psychiatry; 2016 Feb; 73(2):166-74. PubMed ID: 26720179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.
    Kubo H; Nakataki M; Sumitani S; Iga JI; Numata S; Kameoka N; Watanabe SY; Umehara H; Kinoshita M; Inoshita M; Tamaru M; Ohta M; Nakayama-Yamauchi C; Funakoshi Y; Harada M; Ohmori T
    J Affect Disord; 2017 Jan; 208():139-144. PubMed ID: 27770643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?
    Hermens DF; Chitty KM; Kaur M
    Schizophr Res; 2018 Jan; 191():132-139. PubMed ID: 28450056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
    Yildiz-Yesiloglu A; Ankerst DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):969-95. PubMed ID: 16677749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting-state glutamatergic neurotransmission is related to the peak latency of the auditory mismatch negativity (MMN) for duration deviants: An (1)H-MRS-EEG study.
    Kompus K; Westerhausen R; Craven AR; Kreegipuu K; Põldver N; Passow S; Specht K; Hugdahl K; Näätänen R
    Psychophysiology; 2015 Sep; 52(9):1131-9. PubMed ID: 25917405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.
    Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):985-991. PubMed ID: 29789269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder.
    Ehrlich A; Schubert F; Pehrs C; Gallinat J
    Psychiatry Res; 2015 Aug; 233(2):73-80. PubMed ID: 26050195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
    Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y
    J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.
    Kim SY; Kaufman MJ; Cohen BM; Jensen JE; Coyle JT; Du F; Öngür D
    Biol Psychiatry; 2018 Mar; 83(6):484-491. PubMed ID: 29031411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.
    Gigante AD; Bond DJ; Lafer B; Lam RW; Young LT; Yatham LN
    Bipolar Disord; 2012 Aug; 14(5):478-87. PubMed ID: 22834460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch Negativity and Cortical Thickness in Patients With Schizophrenia and Bipolar Disorder.
    Kim S; Jeon H; Jang KI; Kim YW; Im CH; Lee SH
    Schizophr Bull; 2019 Mar; 45(2):425-435. PubMed ID: 29684224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity.
    Pentz AB; Timpe CMF; Normann EM; Slapø NB; Melle I; Lagerberg TV; Steen NE; Westlye LT; Jönsson EG; Haukvik UK; Moberget T; Andreassen OA; Elvsåshagen T
    Schizophr Res; 2023 Nov; 261():80-93. PubMed ID: 37716205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.
    Soeiro-de-Souza MG; Henning A; Machado-Vieira R; Moreno RA; Pastorello BF; da Costa Leite C; Vallada H; Otaduy MC
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2221-9. PubMed ID: 26476706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study.
    Haarman BC; Burger H; Doorduin J; Renken RJ; Sibeijn-Kuiper AJ; Marsman JB; de Vries EF; de Groot JC; Drexhage HA; Mendes R; Nolen WA; Riemersma-Van der Lek RF
    Brain Behav Immun; 2016 Aug; 56():21-33. PubMed ID: 26348581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.